Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Cardio Diagnostics Holdings, Inc.CDIO · Entity 8239 | Director | September 30, 2026 | October 02, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Cardio Diagnostics Holdings, Inc.
Report date September 30, 2026 · Filed October 02, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Options (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.90 · Expires 2036-09-30 | Direct | 15,656 |
Reported balance
After 2026-09-30 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-09-30 · Grant · Acquired 3,286 · Balance 15,656 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 30, 2026 Filed Oct 2, 2026 21:38 UTC | Cardio Diagnostics Holdings, Inc. CDIO · Entity 8239 | GrantStock Options (Right to Buy) · Derivative | 3,286 | $1.90 Strike: $1.90 | $6,243.40 |
DisclosureSEC source: 0002055040-26-000004 · primary_doc.xml · derivative · entry 1 Betts Wendy J · CIK 0002055040 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,656 Underlying: Common Stock · 3,286 shares Expires 2036-09-30 Read SEC document |
| June 30, 2026 Filed Jul 2, 2026 16:27 UTC | Cardio Diagnostics Holdings, Inc. CDIO · Entity 8239 | GrantStock Options (Right to Buy) · Derivative | 2,854 | $2.19 Strike: $2.19 | $6,250.26 |
DisclosureSEC source: 0002055040-26-000003 · primary_doc.xml · derivative · entry 1 Betts Wendy J · CIK 0002055040 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,367 Underlying: Common Stock · 2,854 shares Expires 2036-06-30 Read SEC document |
| March 31, 2026 Filed Apr 2, 2026 18:18 UTC | Cardio Diagnostics Holdings, Inc. CDIO · Entity 8239 | GrantStock Options (Right to Buy) · Derivative | 3,205 | $1.95 Strike: $1.95 | $6,249.75 |
DisclosureSEC source: 0002055040-26-000002 · primary_doc.xml · derivative · entry 1 Betts Wendy J · CIK 0002055040 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,513 Underlying: Common Stock · 3,205 shares Expires 2036-03-31 Read SEC document |
| December 31, 2025 Filed Jan 6, 2026 19:17 UTC | Cardio Diagnostics Holdings, Inc. CDIO · Entity 8239 | GrantStock Options (Right to Buy) · Derivative | 2,306 | $2.71 Strike: $2.71 | $6,249.26 |
DisclosureSEC source: 0002055040-26-000001 · primary_doc.xml · derivative · entry 1 Betts Wendy J · CIK 0002055040 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,308 Underlying: Common Stock · 2,306 shares Expires 2035-12-31 Read SEC document |
| September 30, 2025 Filed Oct 3, 2025 20:20 UTC | Cardio Diagnostics Holdings, Inc. CDIO · Entity 8239 | GrantStock Options (Right to Buy) · Derivative | 1,559 | $4.01 Strike: $4.01 | $6,251.59 |
DisclosureSEC source: 0002055040-25-000002 · primary_doc.xml · derivative · entry 1 Betts Wendy J · CIK 0002055040 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,002 Underlying: Common Stock · 1,559 shares Expires 2035-09-30 Read SEC document |
| June 30, 2025 Filed Jul 2, 2025 23:07 UTC | Cardio Diagnostics Holdings, Inc. CDIO · Entity 8239 | GrantStock Options (Right to Buy) · Derivative | 1,736 | $3.60 Strike: $3.60 | $6,249.60 |
DisclosureSEC source: 0001486189-25-000021 · primary_doc.xml · derivative · entry 1 Betts Wendy J · CIK 0002055040 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,443 Underlying: Common Stock · 1,736 shares Expires 2035-06-30 Read SEC document |
| March 31, 2025 Filed Apr 1, 2025 17:17 UTC | Cardio Diagnostics Holdings, Inc. CDIO · Entity 8239 | GrantStock Options (Right to Buy) · Derivative | 18,939 | $0.33 Strike: $0.33 | $6,249.87 |
DisclosureSEC source: 0001486189-25-000008 · primary_doc.xml · derivative · entry 1 Betts Wendy J · CIK 0002055040 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,211 Underlying: Common Stock · 18,939 shares Expires 2035-03-31 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.